WATER IV Prostate Cancer
NCT: NCT06651632 · ACTIVE_NOT_RECRUITING
Brief Summary
This is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, prostatectomy. Participants will be randomized to either Aquablation Therapy or radical prostatectomy and followed up to 10 years.
Frequently Asked Questions
What is WATER IV Prostate Cancer?
WATER IV Prostate Cancer is a clinical trial registered under NCT06651632. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06651632?
The current status of NCT06651632 (WATER IV Prostate Cancer) is: ACTIVE_NOT_RECRUITING.
When did WATER IV Prostate Cancer start?
WATER IV Prostate Cancer started on 2025-02-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.